Bevacizumab in Advanced Cervical Cancer: Issues and Challenges for Low- and Middle-Income Countries. (Q33859790)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

Bevacizumab in Advanced Cervical Cancer: Issues and Challenges for Low- and Middle-Income Countries (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference

cervix uterine cancer

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

Mahesh Iddawela

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

27 July 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json

Journal of global oncology

25 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

93-97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json

Compensatory angiogenesis and tumor refractoriness

25 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

First- and second-line bevacizumab in addition to chemotherapy for metastatic colorectal cancer: a United States-based cost-effectiveness analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: is it cost-effective?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

Improved survival with bevacizumab in advanced cervical cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

Preventing cancer with vaccines: progress in the global control of cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

Worldwide burden of cervical cancer in 2008.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

HPV screening for cervical cancer in rural India

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

Changing paradigms in the systemic treatment of advanced cervical cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

Cost-effectiveness of cervical-cancer screening in five developing countries

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5493276

Bevacizumab in advanced cancer, too much or too little?

29 October 2018

1 reference

12 December 2020

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

1 reference

12 December 2020

Improved drug access in low and middle-income countries

1 reference

12 December 2020

1 reference

12 December 2020

Novel Humanitarian Aid Program: The Glivec International Patient Assistance Program-Lessons Learned From Providing Access to Breakthrough Targeted Oncology Treatment in Low- and Middle-Income Countries

1 reference

12 December 2020

Identifiers

DOI

10.1200/JGO.2016.004895

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json

release_bdff7v3gifgzvlfl67l67glpxq

25 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bdff7v3gifgzvlfl67l67glpxq

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28717748%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

PubMed publication ID

28717748

1 reference